Simcere Pharmaceutical IPO: Valuation Insights
We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range
543 Views
Simcere (å 声å¶čÆ) IPO: Fairly Valued for a Generic Player
We think the company is fairly valued but will participate in the deal given the likely strong sentiment as the deal is backed by decent...
424 Views
ECM Weekly (11 October 2020) - Excellence Comm, MR DIY, Converge ICT, Simcere, SciClone, JW Thera
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
517 Views
A Different Angle -Ā Simcere Pharmaceutical VS Everest Medicines (01952.HK)
Everest Medicines was listed in Hong Kong stock market on October 9, 2020 and closed at HK$72.75 (up 32.27% on the first day) . From the...
507 Views
Simcere Pharmaceutical IPO Initiation: A Rough Patch?
The timing of the IPO is not ideal as Simcere is coming off a weak 1H20. However, Simcere is putting in place the right measures to ensure that the...
492 Views